Journal article
Random effects modelling versus logistic regression for the inclusion of cluster-level covariates in propensity score estimation: a Monte Carlo simulation and registry cohort analysis
- Abstract:
-
Purpose: Surgeon and hospital-related features, such as volume, can be associated with treatment choices and outcomes. Accounting for these covariates with propensity score (PS) analysis can be challenging due to the clustered nature of the data. We studied six different PS estimation strategies for clustered data using random effects modelling (REM) compared with logistic regression.
Methods: Monte Carlo simulations were used to generate variable cluster-level confounding intensity [odds ratio (OR) = 1.01–2.5] and cluster size (20–1,000 patients per cluster). The following PS estimation strategies were compared: i) logistic regression omitting cluster-level confounders; ii) logistic regression including cluster-level confounders; iii) the same as ii) but including cross-level interactions; iv), v), and vi), similar to i), ii), and iii), respectively, but using REM instead of logistic regression. The same strategies were tested in a trial emulation of partial versus total knee replacement (TKR) surgery, where observational versus trial-based estimates were compared as a proxy for bias. Performance metrics included bias and mean square error (MSE).
Results: In most simulated scenarios, logistic regression, including cluster-level confounders, led to the lowest bias and MSE, for example, with 50 clusters × 200 individuals and confounding intensity OR = 1.5, a relative bias of 10%, and MSE of 0.003 for (i) compared to 32% and 0.010 for (iv). The results from the trial emulation also gave similar trends.
Conclusion: Logistic regression, including patient and surgeon-/hospital-level confounders, appears to be the preferred strategy for PS estimation.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 3.6MB, Terms of use)
-
- Publisher copy:
- 10.3389/fphar.2023.988605
Authors
- Publisher:
- Frontiers Media
- Journal:
- Frontiers in Pharmacology More from this journal
- Volume:
- 14
- Article number:
- 988605
- Place of publication:
- Switzerland
- Publication date:
- 2023-03-23
- Acceptance date:
- 2023-03-07
- DOI:
- EISSN:
-
1663-9812
- Pmid:
-
37033623
- Language:
-
English
- Keywords:
- Pubs id:
-
1336997
- Local pid:
-
pubs:1336997
- Deposit date:
-
2023-08-15
Terms of use
- Copyright holder:
- Du et al
- Copyright date:
- 2023
- Rights statement:
- © 2023 Du, Prats-Uribe, Khalid, Prieto-Alhambra and Strauss. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record